FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Acetate Injection
Status: Currently in Shortage
»Date first posted: 02/03/2016
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Reverified 04/24/2025)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)	Available	Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Reverified 04/23/2025)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)	Available
Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)	Limited Availability	Limited Supply Available. Next Delivery: April 2025; Estimated Recovery: June 2025.	Other
Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)	Available
Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)	Available
Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)	Available
Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)	Available

Milla Pharmaceuticals (Revised 04/21/2025)

Company Contact Information:
833-251-8463

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 69784-232-01)	Limited Availability	Limited Availability	Other
Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 69784-229-10)	Available
Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)	Available
Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)	Available